Hydrochlorothiazid: the pathway in the body

Hydrochlorothiazid is part of the pathway “Hydrochlorothiazid”. This page shows the whole pathway; the station of Hydrochlorothiazid is highlighted.

Where this laboratory value sits: Hydrochlorothiazide — tablet, swallowed. Hydrochlorothiazide is swallowed as a tablet. The label places it among the thiazides and describes it as a derivative of chlorothiazide. It halts the Na-Cl cotransporter, so more salt passes into the urine. Source 8

In brief

Hydrochlorothiazide is a thiazide. It acts from the urine side and settles, in the first part of the distal convoluted tubule, on the Na-Cl cotransporter — the protein that reclaims sodium and chloride together from the urine. More sodium and chloride thus enter the urine.

What this is about

The kidney filters blood and reclaims from the prefiltered fluid whatever the body is to keep. In the first part of the convoluted tubule it works like this:

The Na-Cl cotransporter NCC brings sodium and chloride together into the cell. On the blood side the sodium-potassium pump passes the sodium on to the blood and so holds the gradient.
What is not reclaimed here flows on into the collecting duct. There sodium enters the cell through the channel ENaC, and in the same move the cell hands potassium into the urine.
The fine tuning of calcium and magnesium runs through the same segment, via the channels TRPV5 and TRPM6.

Hydrochlorothiazide settles on the NCC and halts its passage. Sodium and chloride are no longer reclaimed together here — the label describes both going into the urine in roughly equal amounts, accompanied by a loss of potassium and bicarbonate. For calcium it runs the other way: with the NCC occupied, a stronger reclaim is described, unlike with loop diuretics. For magnesium and for zinc a greater output into the urine is described.

What this means in an individual case depends on many things and belongs in a conversation with a doctor or health practitioner.

Source 1, 2, 3, 4, 6, 7, 8

14 stations · 9 sources

Swipe the graphic sideways

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

Hydrochlorothiazide → Passage into the blood From the small bowel the substance passes into the blood and reaches the kidney with it. The label states that it is not metabolised in the body. What circulates in the blood is thus already the active form. Source 8↑ supplies The substance reaches the kidney via the blood. As the body does not metabolise it, what circulates in the blood is already the form that later acts at the transporter. established physiology Source 8
⚖ When the balance tips

too much — If a lot of active substance is present in the blood, the kidney passes correspondingly more of it into the urine; the label names no other route out of the body.

too little — If little active substance is present in the blood, little of it reaches the urine side of the tubule either, and the NCC stays largely free.

established physiology · Source 8, 1
Passage into the blood → On into the urine The kidney eliminates the substance rapidly and largely unchanged. It thus reaches the tubule from the inside — from the urine side, where its binding site also lies. Elimination is thus also the route to the site of action. Source 8, 1↑ supplies Only in the urine does the substance reach its binding site, because the NCC sits in the wall facing the urine. Elimination by the kidney is thus also the route to the site of action. established physiology Source 8, 1
⚖ When the balance tips

too much — If a lot of the substance enters the tubular fluid, a large share of the binding sites on the NCC is occupied, and more sodium and chloride flow on.

too little — If little of the substance enters the tubular fluid, only a small share of the binding sites on the NCC is occupied, and the reclaim runs largely as usual.

established physiology · Source 1, 8
Sodium and chloride → Inside the tubule cell NCC · sodium, chloride The NCC carries one sodium and one chloride particle together; both pass only side by side. With hydrochlorothiazide in place, this reclaim does not happen. What comes in is kept by the body. Source 1, 8↑ supplies The sodium and chloride brought in pass on from the cell into the blood and are thus kept by the body. With the NCC occupied, this uptake does not happen. established physiology Source 1, 8
⚖ When the balance tips

too much — If the NCC brings in a lot of sodium, more salt stays in the body and less sodium reaches the collecting duct; less potassium is then released there too.

too little — If little sodium enters the cell, its sodium content falls; in animal models the cell is described as then absorbing more calcium through TRPV5 and NCX1.

observed in studies · Source 1, 4, 3
Inside the tubule cell → Back into the blood Na-K-ATPase · Mg-ATP On the side facing the blood, the sodium-potassium pump moves sodium out and potassium in. It splits ATP to do so and holds the gradient that lets the NCC work. With little ATP, the gradient flattens. Source 5, 1↑ supplies The pump passes the sodium on to the blood and keeps it low inside the cell. The NCC draws its drive from this gradient; the energy for it comes from ATP. established physiology Source 5, 1
⚖ When the balance tips

too much — If the pump works hard, sodium in the cell falls and the gradient for the NCC becomes steeper; at the same time it brings more potassium into the cell.

too little — If little ATP is available to the pump, sodium in the cell rises, the gradient flattens, and the NCC brings in less sodium and chloride.

established physiology · Source 5, 1
Sodium and chloride → What is left over What is not reclaimed at the NCC flows on. The label states that the substance sends sodium and chloride into the urine in roughly equal amounts. Water goes into the urine along with the salt. Source 8, 1↓ depletes What flows on here largely leaves the body with the urine. Sodium and chloride carry water with them; more salt and water thus leave. established physiology Source 8
⚖ When the balance tips

too much — If a lot of sodium flows on, more of it reaches the collecting duct; there the cell exchanges more sodium for potassium, and more potassium enters the urine.

too little — If little flows on because the NCC works freely, this segment reclaims most of it, and the collecting duct receives little sodium for the exchange against potassium.

established physiology · Source 4, 8, 1
What is left over → In the collecting duct ENaC In the collecting duct sodium enters the cell through the channel ENaC. How much arrives there depends on how much was reclaimed further up. The more sodium enters here, the more potassium is released. Source 4↑ supplies Through ENaC the collecting duct reclaims part of the sodium flowing on. The entry charges the tubular fluid negatively, and this pull drives potassium out of the cell. established physiology Source 4
⚖ When the balance tips

too much — If a lot of sodium flows in through ENaC, for instance when more arrives or aldosterone inserts more channels, the tubular fluid becomes more negative and more potassium is released.

too little — If little sodium flows in, the negative charge in the tubular fluid stays weak, and the cell releases little potassium.

established physiology · Source 4
In the collecting duct → Potassium into urine Na-K pump · potassium in exchange As sodium enters through ENaC, the cell hands potassium into the urine in the same move. Alongside the sodium output the label names a loss of potassium and bicarbonate. This potassium leaves the body with the urine. Source 4, 8↓ depletes The potassium released is lost with the urine. The more sodium arrives in the collecting duct and the more urine flows, the more potassium leaves the body. established physiology Source 4, 8
⚖ When the balance tips

too much — If a lot of potassium enters the urine, potassium in the blood falls; the kidney then reduces release in the collecting duct, and cells release potassium into the blood.

too little — If little potassium enters the urine, more stays in the body; if potassium in the blood rises, it stimulates the formation of aldosterone, which raises release in the collecting duct again.

established physiology · Source 4
Calcium in the tubule → More calcium reclaimed TRPV5, NCX1 With the NCC occupied, a stronger reclaim of calcium is described — unlike with loop diuretics. Two places are named for it: the proximal segment and the convoluted tubule itself. Less calcium thus enters the urine. Source 2, 3↑ supplies Under thiazides less calcium enters the urine and more of it stays in the body. A stronger uptake in the proximal segment and in the convoluted tubule itself are discussed as the sites. observed in studies Source 2, 3
⚖ When the balance tips

too much — If a lot of calcium is reclaimed, correspondingly less leaves with the urine, and more calcium stays in the blood.

too little — If little extra is reclaimed, calcium enters the urine as usual; with loop diuretics, by contrast, more calcium leaves.

observed in studies · Source 2, 3
Magnesium at TRPM6 → Magnesium in the urine TRPM6 Under thiazides, a smaller amount of TRPM6 in the convoluted tubule and a greater output of magnesium with the urine are described. This magnesium leaves the body. Source 2, 6↓ depletes Magnesium in the urine leaves the body. Under thiazides less TRPM6 is described in the convoluted tubule, so that more magnesium follows this route. observed in studies Source 2, 6
⚖ When the balance tips

too much — If a lot of magnesium enters the urine, the body's store falls over time; bound to ATP, magnesium is needed by many enzymes and by the sodium-potassium pump.

too little — If little magnesium enters the urine, the store is kept; gut and bone additionally even out fluctuations in the blood.

established physiology · Source 6

Further stations

Hydrochlorothiazide — tablet, swallowed Hydrochlorothiazide is swallowed as a tablet. The label places it among the thiazides and describes it as a derivative of chlorothiazide. It halts the Na-Cl cotransporter, so more salt passes into the urine. Source 8↓ depletes Hydrochlorothiazide inhibits the Na-Cl cotransporter in the distal convoluted tubule. Sodium and chloride that it would otherwise reclaim stay in the urine and leave in roughly equal amounts. established physiology Source 8, 1
⚖ When the balance tips

too much — If a lot of active substance is present, a larger share of the NCC binding sites is occupied; once all are filled, further substance changes nothing more at the transporter.

too little — If little active substance is present, most NCC stay free and reclaim sodium and chloride from the urine as usual.

established physiology · Source 1, 8
At the binding site — of the Na-Cl cotransporter The Na-Cl cotransporter NCC sits in the wall facing the urine, in the first part of the distal convoluted tubule. Thiazides settle at that site. Once occupied, it brings in no more sodium and chloride. Source 1↓ depletes When hydrochlorothiazide occupies the binding site, the NCC can bring in no more sodium and chloride. This is the core of the action; all further steps on the map follow from it. established physiology Source 1, 8
⚖ When the balance tips

too much — If a lot of NCC is built into the wall and switched on by attached phosphate, the segment reclaims more sodium and chloride, and the body retains more salt.

too little — If little NCC is active, more sodium and chloride reach the collecting duct; there part of it is reclaimed through ENaC, in exchange for potassium.

established physiology · Source 1, 4
Sodium and chloride — in the tubular fluid Prefiltered fluid flows past in the first part of the distal convoluted tubule. It carries sodium and chloride, which the body can reclaim here. If much sodium arrives, the NCC reclaims more of it. Source 1↑ supplies Sodium and chloride in the passing fluid are the material that the NCC reclaims. The more of it arrives, the more this segment can absorb. established physiology Source 1
⚖ When the balance tips

too much — If a lot of sodium arrives, the NCC absorbs more of it until it is working at capacity; the rest flows on into the collecting duct.

too little — If little sodium arrives, the segment reclaims little, and little reaches the collecting duct either; less potassium is then released there in exchange.

established physiology · Source 1, 4
Calcium in the tubule — in through TRPV5 In the convoluted tubule the cell also reclaims calcium: in through the channel TRPV5 and out through the exchanger NCX1 on the blood side. This is controlled by parathyroid hormone. Source 2↑ supplies Through TRPV5 and NCX1 this segment reclaims calcium that would otherwise leave with the urine. This is where calcium excretion is finely set. established physiology Source 2
⚖ When the balance tips

too much — If there is a lot of calcium in the blood, parathyroid hormone, which otherwise stimulates TRPV5, falls; the segment then reclaims less, and more calcium enters the urine.

too little — If there is little calcium in the blood, parathyroid hormone rises and stimulates the reclaim through TRPV5, so that less calcium enters the urine.

established physiology · Source 2
Magnesium at TRPM6 — channel in the same segment The fine tuning of magnesium runs through the channel TRPM6 in that same segment. What it does not bring in stays in the urine. This is where the last magnesium is reclaimed. Source 6, 2↑ supplies Through TRPM6 this segment reclaims the last magnesium that can still be recovered. What is not absorbed here enters the urine. established physiology Source 6, 2
⚖ When the balance tips

too much — If there is a lot of magnesium in the blood, the kidney reclaims less and more enters the urine; it thus holds the magnesium level.

too little — If there is little magnesium in the blood, the kidney reclaims more, in the convoluted part through TRPM6, which offers the last opportunity for it.

established physiology · Source 6

What the kidney handles differently

Sodium — The NCC reclaims sodium together with chloride from the tubule; occupy it and that reclaim does not happen Source 1, 8
Potassium — More sodium reaches the collecting duct; there the cell hands potassium into the urine in the same move; blood K⁺ falls Source 4, 8
Calcium — With the NCC occupied, a stronger reclaim of calcium is described, unlike with loop diuretics Source 2, 3
Magnesium — In the convoluted tubule, less TRPM6 and a greater output of magnesium with the urine are described Source 2, 6
Zinc — A systematic review of clinical studies names a greater output of zinc into the urine for hydrochlorothiazide alone Source 7

What takes part in these steps

Chloride — The NCC carries chloride together with sodium; both particles pass only side by side; otherwise it stays in the urine Source 1, 8
ATP — The sodium-potassium pump splits ATP and so holds the gradient from which the NCC draws its drive; bound to magnesium Source 5

What the prescribing information states

The prescribing information for this substance comes from an older labelling format. It lists the reported reactions by organ system and gives neither frequencies nor a comparator or placebo group; figures stand there only for the reports after approval. The table repeats what stands there under each heading.

How to read this table: apart from the last row it holds no figures, because the label gives none. Without a comparison group it cannot be said how often a reaction occurs, nor whether it would be rarer without the substance. The figures in the last row are given as additional cases per patients per year, not as a share. The order within a row comes from the label: it starts with the most severe.

	What the prescribing information lists there
Body as a whole	Weakness
Heart and circulation	Pressure in the circulation too low, also on standing up
Digestion	Pancreatitis, jaundice from bile stasis in the liver, diarrhoea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea, loss of appetite
Blood counts	Aplastic anaemia, agranulocytosis, leucopenia, haemolytic anaemia, thrombocytopenia
Hypersensitivity	Anaphylactic reactions, necrotising angiitis (vasculitis, also of the skin), respiratory distress including pneumonitis and fluid in the lungs, photosensitivity, fever, urticaria, rash, purpura
Metabolism	Shift in the salts, raised sugar in the blood, sugar in the urine, raised uric acid
Muscle	Muscle spasm
Nervous system and mind	Vertigo, paraesthesias, dizziness, headache, restlessness
Kidney	Renal failure, reduced kidney function, interstitial nephritis
Skin	Erythema multiforme including Stevens-Johnson syndrome, exfoliative dermatitis including toxic epidermal necrolysis, alopecia
Senses	Transient blurred vision, xanthopsia
Urinary and genital organs	Erectile difficulty
After approval	Non-melanoma skin cancer: Hydrochlorothiazide is associated with an increased risk of non-melanoma skin cancer. In a study conducted in the Sentinel System, increased risk was predominantly for squamous cell carcinoma (SCC) and in white patients taking large cumulative doses. The increased risk for SCC in the overall population was approximately 1 additional case per 16,000 patients per year, and for white patients taking a cumulative dose of ≥50,000 mg the risk increase was approximately 1 additional SCC case for every 6,700 patients per year.

The last row stands in the prescribing information under the heading “Postmarketing Experience”; it reproduces what was evaluated there after approval. The prescribing information closes the section with a note, addressed to prescribers, on how to proceed when adverse reactions are moderate or severe.

Sources

Rioux AV, Nsimba-Batomene TR, Slimani S et al. Navigating the multifaceted intricacies of the Na(+)-Cl(-) cotransporter, a highly regulated key effector in the control of hydromineral homeostasis. Physiol Rev 2024 · PubMed 38329422
Alexander RT, Dimke H. Effect of diuretics on renal tubular transport of calcium and magnesium. Am J Physiol Renal Physiol 2017 · PubMed 28274923
Reilly RF, Huang CL. The mechanism of hypocalciuria with NaCl cotransporter inhibition. Nat Rev Nephrol 2011 · PubMed 21947122
Palmer BF. Regulation of Potassium Homeostasis. Clin J Am Soc Nephrol 2015 · PubMed 24721891
Clausen MV, Hilbers F, Poulsen H. The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease. Front Physiol 2017 · PubMed 28634454
Kröse JL, de Baaij JHF. Magnesium biology. Nephrol Dial Transplant 2024 · PubMed 38871680
Braun LA, Rosenfeldt F. Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy. Int J Clin Pract 2013 · PubMed 23279674
US prescribing information (United States): Hydrochlorothiazide Tablets USP, DailyMed, version of 24 Sept 2026, sections DESCRIPTION, CLINICAL PHARMACOLOGY and Pharmacokinetics and Metabolism · Prescribing information
US prescribing information (United States): Hydrochlorothiazide Tablets USP, DailyMed, version of 24 Sept 2026, section ADVERSE REACTIONS · Prescribing information

Whole pathway: Hydrochlorothiazid

As of 2026-09-25. Draft, written by Claude to schema v2; sources checked in PubMed; expert approval pending
Legal notice Privacy policy All biomarkers